RGEN

Repligen Corp

180.01

Oct 21 • 3:59 PM ET +1.13 (0.63%)

180.01

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Instruments & Supplies USA Large NASD

Peers: AVTR DHR TMO WST BIO STVN TECH WAT A MTD

| Held by: IJH VTI VB VBK VXF FBT MDY DFAS IBB SPMD

Scroll to Statements

Index	-
Market Cap	11.43B
Enterprise Value	11.31B
Income	41.54M
Sales	785.10M
Book/sh	37.43
Cash/sh	12.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2000
IPO	Apr 29, 1986

P/E	245.35
Forward P/E	67.88
PEG	2.54
P/S	14.56
P/B	4.81
P/C	14.10
P/FCF	103.76
EV/EBITDA	63.22
EV/Sales	14.41
Quick Ratio	7.64
Current Ratio	9.05
Debt/Eq	0.33
LT Debt/Eq	0.32
Option/Short	Yes / Yes

EPS (ttm)	0.73
EPS next Y	2.65
EPS next Q	0.46
EPS this Y	20.46%
EPS next Y	28.74%
EPS next 5Y	26.72%
EPS past 3/5Y	-35.60% -4.91%
Sales past 3/5Y	-2.70% 15.05%
EPS Y/Y TTM	397.90%
Sales Y/Y TTM	16.49%
EPS Q/Q	-66.40%
Sales Q/Q	11.93%
Earnings	Oct 27 BMO
EPS/Sales Surpr.	20.81% 1.26%

Insider Own	5.56%
Insider Trans	-1.05%
Inst Own	111.69%
Inst Trans	5.37%
ROA	1.42%
ROE	1.99%
ROIC	1.49%
Gross Margin	48.79%
Oper. Margin	9.03%
Profit Margin	5.29%
SMA20	-0.29%
SMA50	1.90%
SMA200	24.73%
Trades

Shs Outstand	63.49M
Shs Float	59.96M
Short Float	12.64%
Short Ratio	6.26
Short Interest	7.58M
52W High	198.87 -9.48%
52W Low	100.99 78.25%
Volatility	5.10% 5.15%
ATR (14)	8.57
RSI (14)	52.29
Beta	1.11
Rel Volume	0.75
Avg Volume	1.21M
Volume	903,822

Perf Week	1.02%
Perf Month	-3.61%
Perf Quarter	30.82%
Perf Half Y	44.70%
Perf YTD	9.86%
Perf Year	14.84%
Perf 3Y	23.32%
Perf 5Y	-33.52%
Perf 10Y	515.42%
Recom	1.55
Target Price	200.33
Prev Close	178.88
Price	180.01
Change %	0.63%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Buy	$225
Jul-07-26	Upgrade	The Benchmark Company	Hold → Buy	$185
Jun-02-26	Resumed	Wolfe Research	Outperform	$145
May-15-26	Resumed	RBC Capital Mkts	Outperform	$160
Apr-17-26	Initiated	Rothschild & Co Redburn	Buy	$160
Oct-01-25	Initiated	HSBC Securities	Buy	$150
Sep-22-25	Upgrade	Evercore ISI	In-line → Outperform	$155
Jul-22-25	Resumed	Stephens	Overweight	$160
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220

Show Previous Ratings

Oct-13-26 07:30AM	Repligen to Report Third Quarter 2026 Financial Results (GlobeNewswire)
Oct-06-26 09:05AM	Repligen Completes Acquisition of BioLife Solutions (GlobeNewswire) -7.73%
Oct-05-26 06:29PM	Freshworks Set to Join S&P SmallCap 600 (PR Newswire)
05:54PM	Freshworks stock climbs on S&P SmallCap 600 inclusion (Investing.com)
Sep-29-26 12:23AM	Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? (Stocktwits)
07:30AM	Loading…
Aug-26-26 07:30AM	Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
Aug-19-26 02:21PM	These Two Biotech Stocks Recorded Fresh Milestones Today Whats Driving Todays Gains? (Stocktwits) +6.15%
Jul-28-26 03:01PM	Repligen Corp (RGEN) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidance Amidst ... (GuruFocus.com) +10.90%
10:05AM	Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance (InvestorsHub)
07:10AM	Repligen: Q2 Earnings Snapshot (Associated Press)
07:00AM	Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance (GlobeNewswire)
Jul-22-26 06:00AM	Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media (GlobeNewswire)
Jul-15-26 07:30AM	Repligen to Report Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-07-26 09:36AM	SpaceX initiated, Cloudflare upgraded: Wall Street's top analyst calls (The Fly)
May-22-26 07:30AM	Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference (GlobeNewswire)
07:30AM	Loading…
May-20-26 07:30AM	Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report (GlobeNewswire)
May-07-26 07:30AM	Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference (GlobeNewswire)
May-05-26 12:52PM	Repligen Corporation Q1 2026 Earnings Call Summary (Moby) +6.26%
07:36AM	Repligen: Q1 Earnings Snapshot (Associated Press)
07:00AM	Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance (GlobeNewswire)
Apr-22-26 07:30AM	Repligen to Report First Quarter 2026 Financial Results (GlobeNewswire) -6.25%
Apr-17-26 09:36AM	Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls (The Fly)
07:30AM	Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network (GlobeNewswire)
Mar-05-26 07:30AM	Repligen Corporation to Present at Upcoming March Conferences (GlobeNewswire)
Mar-02-26 11:06PM	3 Reasons to Avoid RGEN and 1 Stock to Buy Instead (StockStory)
Feb-25-26 01:47PM	Analyst Report: Repligen Corporation (Morningstar Research)
09:10AM	Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
Feb-24-26 04:32PM	Repligen Corporation Q4 2025 Earnings Call Summary (Moby)
04:02PM	Repligen Corp (RGEN) Q4 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... (GuruFocus.com)
12:49PM	Repligen Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Loading…
09:40AM	Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:47AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:37AM	Repligen (NASDAQ:RGEN) Exceeds Q4 CY2025 Expectations (StockStory)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance (GlobeNewswire)
Feb-22-26 10:13PM	Repligen (RGEN) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-19-26 11:43PM	2 of Wall Street's Favorite Stocks Worth Investigating and 1 We Avoid (StockStory)
Feb-10-26 07:30AM	Repligen to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-06-26 08:16AM	What Makes Repligen Corporation (RGEN) an Investment Choice? (Insider Monkey)
Feb-04-26 08:04PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-26-26 11:01PM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Jan-22-26 09:52PM	UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds (Insider Monkey)
Jan-14-26 02:15PM	Why Repligen (RGEN) Shares Are Sliding Today (StockStory)
Jan-06-26 07:30AM	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair (GlobeNewswire)
Dec-18-25 07:30AM	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Dec-17-25 08:35AM	Here's Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) (Insider Monkey)
Dec-16-25 07:30AM	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows (GlobeNewswire)
Dec-07-25 11:35PM	1 Volatile Stock to Target This Week and 2 We Turn Down (StockStory)
Dec-03-25 11:30AM	Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report? (Zacks)
Nov-26-25 07:30AM	Repligen Corporation to Present at Evercore Healthcare Conference (GlobeNewswire)
Nov-21-25 07:09PM	Analyst Report: Repligen Corporation (Morningstar Research) +5.28%
06:36PM	Why Repligen (RGEN) Stock Is Trading Up Today (StockStory)
Nov-06-25 10:31PM	Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Nov-04-25 07:30AM	Repligen Corporation to Present at Upcoming November Conferences (GlobeNewswire)
12:32AM	5 Revealing Analyst Questions From Repligen's Q3 Earnings Call (StockStory)
Oct-30-25 07:45PM	Analyst Report: Repligen Corporation (Morningstar Research)
Oct-29-25 01:13PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:18AM	RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down (Zacks)
09:40AM	RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset (StockStory)
Oct-28-25 02:35PM	Why Repligen (RGEN) Shares Are Trading Lower Today (StockStory) -5.92%
08:45AM	Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
08:01AM	Repligen's (NASDAQ:RGEN) Q3 Sales Beat Estimates (StockStory)
07:40AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Oct-27-25 09:22AM	Earnings To Watch: Repligen Corp (RGEN) Reports Q3 2025 Result (GuruFocus.com)
Oct-26-25 11:13PM	Repligen Earnings: What To Look For From RGEN (StockStory)
Oct-23-25 07:15PM	Analyst Report: Repligen Corporation (Morningstar Research)
10:00AM	Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-21-25 11:40AM	ALKS vs. RGEN: Which Stock Is the Better Value Option? (Zacks)
10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-15-25 07:30AM	Repligen to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-09-25 07:46AM	Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? (Insider Monkey)
Oct-01-25 12:20PM	Why Is Repligen (RGEN) Stock Soaring Today (StockStory) +9.08%
Sep-30-25 04:05PM	Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know (StockStory) +7.72%
Sep-24-25 12:04AM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Sep-22-25 11:31PM	Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Sep-16-25 02:51PM	Repligen (RGEN) Stock Is Up, What You Need To Know (StockStory) +5.28%
Sep-12-25 02:26PM	Why Repligen (RGEN) Stock Is Down Today (StockStory)
Aug-22-25 03:40PM	Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know (StockStory)
07:30AM	Repligen Corporation to Present at Upcoming September Conferences (GlobeNewswire)
Aug-20-25 08:42AM	Do Options Traders Know Something About Repligen Stock We Don't? (Zacks)
Aug-12-25 12:53AM	RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty (StockStory) +8.51%
12:35AM	5 Must-Read Analyst Questions From Repligen's Q2 Earnings Call (StockStory)
Aug-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-31-25 07:30AM	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (GlobeNewswire)
Jul-29-25 11:52PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:26PM	Why Repligen (RGEN) Stock Is Up Today (StockStory)
08:45AM	Repligen (RGEN) Lags Q2 Earnings Estimates (Zacks)
08:09AM	Repligen's (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
07:41AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Jul-28-25 09:22AM	Repligen Corp (RGEN) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-27-25 11:06PM	Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-22-25 09:40AM	Netflix downgraded, Intel initiated: Wall Street's top analyst calls (The Fly)
Jul-21-25 09:45AM	Here's Why Repligen (RGEN) is a Strong Growth Stock (Zacks)
Jul-18-25 03:11PM	Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know (StockStory) -6.28%
12:03AM	3 Reasons RGEN is Risky and 1 Stock to Buy Instead (StockStory)
Jul-17-25 07:30AM	Repligen to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Loeillot Olivier	Chief Executive Officer	Oct 05 '26	Option Exercise	154.96	4,202	651,142	49,990	Oct 06 04:18 PM
Loeillot Olivier	Chief Executive Officer	Oct 05 '26	Sale	187.29	5,535	1,036,654	45,788	Oct 06 04:18 PM
Loeillot Olivier	Officer	Oct 05 '26	Proposed Sale	190.00	4,202	798,380		Oct 05 04:10 PM
Loeillot Olivier	Officer	Oct 05 '26	Proposed Sale	178.75	1,333	238,274		Oct 05 01:14 PM
Loeillot Olivier	Chief Executive Officer	Sep 24 '26	Option Exercise	155.11	12,946	2,008,020	56,773	Sep 25 04:09 PM
Loeillot Olivier	Chief Executive Officer	Sep 24 '26	Sale	190.00	12,946	2,459,740	48,369	Sep 25 04:09 PM
Loeillot Olivier	Officer	Sep 24 '26	Proposed Sale	190.00	12,946	2,459,740		Sep 24 05:04 PM
Loeillot Olivier	Chief Executive Officer	Sep 21 '26	Option Exercise	141.79	5,426	769,353	53,795	Sep 22 04:07 PM
Loeillot Olivier	Chief Executive Officer	Sep 21 '26	Sale	180.00	5,426	976,680	48,369	Sep 22 04:07 PM
Loeillot Olivier	Officer	Sep 21 '26	Proposed Sale	180.00	5,426	976,680		Sep 21 03:03 PM
Loeillot Olivier	Chief Executive Officer	Sep 04 '26	Sale	165.90	3,035	503,506	48,369	Sep 08 04:13 PM
Loeillot Olivier	Officer	Sep 04 '26	Proposed Sale	165.90	3,035	503,506		Sep 04 10:01 AM
Loeillot Olivier	Chief Executive Officer	Aug 20 '26	Option Exercise	141.79	5,426	769,353	59,672	Aug 21 04:06 PM
Loeillot Olivier	Chief Executive Officer	Aug 20 '26	Sale	180.00	5,426	976,680	54,246	Aug 21 04:06 PM
Loeillot Olivier	Officer	Aug 20 '26	Proposed Sale	180.00	5,426	976,680		Aug 20 11:53 AM
Garland Jason K	CFO	Jul 16 '26	Sale	150.00	530	79,500	18,829	Jul 17 04:40 PM
Garland Jason K	Officer	Jul 16 '26	Proposed Sale	150.00	530	79,500		Jul 16 01:45 PM
Garland Jason K	CFO	Jun 25 '26	Sale	145.00	733	106,285	19,359	Jun 26 04:05 PM
Garland Jason K	Officer	Jun 25 '26	Proposed Sale	145.00	733	106,285		Jun 25 01:55 PM
MUIR GLENN P	Director	May 07 '26	Option Exercise	38.76	2,434	94,342	39,056	May 08 02:48 PM
Loeillot Olivier	Chief Executive Officer	Apr 21 '26	Sale	140.00	3,832	536,480	54,246	Apr 22 01:26 PM
Loeillot Olivier	Officer	Apr 21 '26	Proposed Sale	140.00	3,832	536,480		Apr 21 12:44 PM
DAWES KAREN A	Director	Dec 17 '25	Sale	161.00	275	44,275	91,821	Dec 18 04:30 PM
MUIR GLENN P	Director	Dec 16 '25	Option Exercise	26.12	3,366	87,920	36,622	Dec 17 04:30 PM
DAWES KAREN A	Director	Dec 17 '25	Proposed Sale	161.00	275	44,275		Dec 17 04:28 PM
Loeillot Olivier	Chief Executive Officer	Nov 25 '25	Sale	170.00	7,041	1,196,970	35,898	Nov 26 04:30 PM
Loeillot Olivier	Officer	Nov 25 '25	Proposed Sale	170.00	7,041	1,196,970		Nov 25 12:06 PM
Bylund James	Chief Operating Officer	Nov 18 '25	Sale	151.21	2,191	331,301	21,520	Nov 19 04:30 PM
Bylund James	Officer	Nov 18 '25	Proposed Sale	151.21	2,191	331,304		Nov 18 04:10 PM
Hunt Anthony	Director	Nov 13 '25	Option Exercise	33.87	2,952	99,984	83,695	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Sale	154.61	20,000	3,092,278	80,743	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Option Exercise	33.87	25,000	846,750	125,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Sale	156.88	25,000	3,921,940	100,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Proposed Sale	154.62	20,000	3,092,327		Nov 13 04:11 PM
Hunt Anthony	Director	Nov 12 '25	Proposed Sale	156.88	25,000	3,921,981		Nov 12 04:37 PM

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

PresidentMr. Olivier Loeillot

CFO & Chief Compliance OfficerMr. Jason K. Garland

Chief Operating OfficerMr. James R. Bylund

AdvisorMr. Anthony J. Hunt

Senior Vice President of Research & DevelopmentMr. Ralf Kuriyel

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RGEN

Repligen Corp

Upgrade your Finviz experience